Rigvir holding is the manufacturer of unique cancer medicine, which is able to find and destroy malignant tumour cells in the human body. This kind of cancer treatment, called oncolytic virotherapy, is evidence based and recognised as safe and effective therapy. Rigvir holding unites a group of companies whose activities are focused on production and development of oncolytic virotherapy cancer medicine.
View Top Employees from RIGVIR Holding| Website | http://rigvir.com |
| Revenue | $6 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2003 |
| Address | 9-7 Teatra St, Riga, Riga, LV |
| Phone | +371 67 716 132 |
| Technologies |
HTML,
Google Analytics,
Bootstrap
+9 more
(view full list)
|
| Industry | Pharmaceuticals, Manufacturing General, Health Care, Marketing and Advertising, Manufacturing, Medical, Pharmaceutical |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular RIGVIR Holding employee's phone or email?
RIGVIR Holding Questions
The RIGVIR Holding annual revenue was $6 million in 2024.
RIGVIR Holding is based in Riga, Riga.
The NAICS codes for RIGVIR Holding are [32541, 32, 3254, 325].
The SIC codes for RIGVIR Holding are [28, 283].
Related Companies
